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Children with cystic fibrosis commonly experience abdominal pain; however this remains poorly characterised. This prospective cross-
sectional study with a longitudinal design, examined the prevalence, causes and effect of pain management via daily diaries, validated
questionnaires for pain characteristics, anxiety status and quality of life. One hundred and thirty CF patients aged 8 to 18 years, regularly followed
at our centre, were questioned on recurrent abdominal pain. Eight patients fulfilled the criteria; all wished to enter the study. Pain management
included behavioural intervention with effective pain relief, and had a positive impact on anxiety and quality of life. This study is the first one to
prospectively assess recurrent abdominal pain in CF. We documented a very low prevalence of 6%. We suggest that, ruling out abdominal
discomfort, only a minority of CF children presented recurrent abdominal pain with a true negative impact on daily life. We emphasise the need
for further studies including larger cohorts.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Children; Abdominal pain1. Introduction
Unrecognised and untreated chronic pain may reduce the
quality of life [1–4] and negatively impact the ability to
participate in disease-related daily care. Cystic fibrosis (CF)
children commonly experience abdominal pain whatever the
severity of disease[5,6] but such studies must be interpreted with
caution since patients were asked to report pain experienced over
a period of time without longitudinal pain assessment; moreover
gastrointestinal investigations aimed at assessing pain aetiology
were missing. Thus, we conducted a prospective cross-sectional
study using Apley's criteria to define recurrent abdominal pain
(RAP): “at least three bouts of pain, severe enough to affect
activities, over a period of not less than 3 months, with attacks in
the year preceding the examination” [7]. The purpose of this study
which included a longitudinal design was to assess the prevalence⁎ Corresponding author. Tel.: +33 1 40034754; fax: +33 1 40034755.
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doi:10.1016/j.jcf.2011.07.010and characteristics of RAP, determine their causes, evaluate the
anxiety level and the quality of life at inclusion, provide pain
management and perform complete re-assessment 6 months later.2. Methods
This cross-sectional study was conducted between October,
2007 and October, 2008 at one CF centre which is part of a
paediatric gastroenterology clinic. Inclusion criteria were: (1)
age 8 to 18 years; (2) diagnosis of CF by sweat chloride testing
or genotyping; (3) regular follow-up visits at Robert Debre
Hospital, AP-HP Paris CF centre; (4) RAP that met Apley's
criteria. Patients were systematically questioned for RAP via a
one-to-one interview by their regular CF physician during their
routine clinical visit. The standard sentence used was “Did you
complain over a period of at least 3 months (and during the year
preceding this consultation) of at least three bouts of abdominal
pain severe enough to affect your ongoing activities either atd by Elsevier B.V. All rights reserved.
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this question, he/she was invited to join the study and patients
and parents gave informed written consent. Demographic data,
co-morbidity CF factors, clinical assessment of pain, physical
examination and investigation for an organic cause of their pain
were recorded. At initial visit (iV), participating children received
five standardised questionnaires: Eland Pain location [8], pain
intensity measured by Faces Pain Scale-Revised (FPS-R) [9], Mc
Gill emotional status [10], R-CMAS anxiety score [11] and
health-related quality of life (CF-QOL) [12]. A 28-day daily pain
diary was given to the patient in order to prospectively assess
bouts of pain. A synthesis meeting attended by the CF referring
physician, the psychologist, the pain team, the patient and parents
analysed individual data so as to offer a pain management
programme. Prior to the final visit (fV) 6 months later, the family
was asked to fill in a 28-day prospective daily pain diary; then a
similar questionnaire panel of re-assessment was performed at
the CF centre.
3. Results
Among the 130 CF patients aged 8 to 18 years of age regularly
followed at our centre, 122 did not present inclusion criteria. Their
mean age (range) was 14.1 years (8.5–17), 85% were pancreatic-
insufficient, 10% presented cirrhosis and 9% had diabetes. Mean
(standard deviation) pulmonary and nutritional statuses respec-
tively evaluated by forced respiratory volume in 1 s (FEV1) and
body mass index (BMI)-z-score were 85%±21 and −0.3±2.9.
On the other hand, only eight corresponded to Apley's definition.
These were 6 males and 2 females with a mean (range) age of
13.6 years [9–17]. Their CF co morbidity factors, pulmonary and
nutritional status are summarised in Table 1. Location of pain
symptoms were epigastric (n=5), right (n=5) or left (n=3) iliac
fossa; many patients reported the presence of more than one
locationwith extra-abdominal sites, including the chest (n=3) and
head (n=1). Pain intensity (for the episode that had caused the
greatest pain) analysed via FPS-R and by verbal written skills inTable 1









1. M, 17 82 −0.97 PS/no/no iV: 8 S
fV: 8 M
2. M, 12 85 −1.13 PI/no/no iV: 4 S
fV: 4 M
3. F, 16 95 0.06 PI/yes/no iV: 4 S
fV: 0 N
4. M, 12 103 −1.67 PI/yes/no iV: 8 S
fV: 5 M
5. M, 18 106 0.35 PS/no/no iV: 2 N
fV: 0 N
6. F, 9 64 0.23 PI/no/no iV: 8 N
fV: 0 N
7. M, 14 80 0.16 PI/no/no iV: 2 M
fV: 0 N
8. M, 11 95 0.18 PI/no/no iV: 3 S
FEV1, forced expiratory volume in 1 s; BMI, body mass index; PS, pancreatic-suffic
initial visit; fV, final visit.the pain diary, pain frequency (number of days with at least one
pain episode) and mean duration of pain are given in Table 1 with
a comparison between initial and final assessment. Questionnaires
on emotional upheaval and anxiety identified high scores in
patients 1 to 4, conversely to the remaining four patients. Table 1
also summarises the individualised pain programme offered to the
patient. Patient 6, who had noted no bouts of pain in the initial
follow-up diary, requested to be withdrawn from the study before
the synthesis meeting. The family of patient 8 moved for
professional reasons and CF follow-up was organised at another
centre. For patients 5 and 7, pain aetiology was identified during
the iV, followed by immediate pain relief after stopping the high
intake of fizzy beverages and optimisation of pancreatic enzyme
supplementation, thus explaining the low initial pain scores in the
prospective follow-up diary. During the synthesis meeting, for
patient 3 we suggested change in scholarship and this resolved the
RAP problem. For patients 1, 2 and 4, who presented high levels
of anxiety with emotional upset in the absence of organic pain
aetiology, complementary therapies with self-hypnosis and
relaxation were offered via regular appointments with the pain
management team; this successfully relieved pain as well as
emotional upheaval, anxiety level and CF-QOL (physical and
social functioning, overall perception of health) during follow-up.
4. Discussion
Surprisingly, in our prospective study involving CF children
and adolescents with mild disease severity, the prevalence of
RAP, as accurately defined by Apley [7], was as low as 6%. We
hypothesise that, by using a definition of RAP, we excluded
from the study many children with less severe pain experience.
In the general population of school-age children, 4% to 25%
complain of RAP of sufficiently severe intensity as to interfere
with daily activities [2].The first published report of chronic
pain in CF concerned young adults with more advanced disease
referred to a pain treatment service with up to 84% of multiple








evere 30 min 4 Behavioural
oderate Shorter 4
evere 1 h 9 Behavioural
oderate Shorter 5
evere 1 h 16 Change in scholarship
o pain No pain No pain
evere Few hours 5 Behavioural
oderate 30 min 8
o pain No pain No pain Stop fizzy beverages
o pain No pain No pain
o pain No pain No pain Withdrawn from study
o pain No pain No pain
oderate 30 min 23 Pancreatic enzyme
o pain No pain No pain
evere 1 h 21 Moved away
ient; PI, pancreatic-insufficient, FPS-R, Faces Pain Scale-Revised intensity; iV,
48 A. Munck et al. / Journal of Cystic Fibrosis 11 (2012) 46–48pain in CF children. In the study by Kho et al. [5] involving a
cohort of 46 children with mild disease severity, chronic pain
was experienced in 46%, mainly located in the abdomen (50%);
it was described as mild (72%) and of relatively short duration
(less than 1 h) (65%) with no or little emotional upset in 76%.
However, in Kho's study cohort, a negative impact of recurrent
pain symptoms on health-related QOL was identified, in
comparison to children with no or less frequent pain [4]. Pain
characteristics did not differ according to age or gender in that
study [5] conversely to the Perquin report [14] which found
more prevalent chronic pain in females and in patients over
12 years of age. In a recent survey of pain in CF patients
throughout their lives, Sermet-Gaudelus et al. [6] outlined a
high incidence of untreated pain; they studied 73 children and
59% reported at least one episode of pain during the previous
month, with prevalent abdominal location (60%) and mean pain
intensity on the FPS-R of 4.9; 15% reported school absenteeism
and one-third of the cohort reported a negative impact on their
family life. Contrary to the study done by Koh et al. [5], the
authors emphasised that CF children experienced intense, long-
lasting and recurrent pain episodes. Nevertheless, interpretation
of these studies may be limited, firstly, because patients were
asked to retrospectively report their pain experience over a
specific period of time and may thus have also reported
abdominal discomfort, as currently reported in healthy children
[1,14,15], and secondly because of the restricted sample size.
In conclusion, our pilot study is the first, using a longitudinal
design to prospectively evaluate RAP, its characteristics and its
management, including behavioural interventions. The unpre-
dictably low prevalence of RAP enabled only a descriptive
analysis of the cohort, thus hampering statistical analysis. We
suggest that, ruling out abdominal discomfort, only a minority
of CF children presented recurrent abdominal pain with a true
negative impact on daily life. Assessment of abdominal pain
should be an integral part of care in CF centres. Nevertheless,
our findings need to be interpreted in the light of several
limitations: the sample was relatively small and was drawn from
one CF centre; thus, we highlight the need for further
prospective longitudinal studies to clarify whether our low
prevalence of RAP can be generalised and to determine the
efficacy of behavioural interventions [2,16–18] for chronic pain
in CF children.
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